Recombinant virus-like particles encoded by multi-gene vector
Abstract
The invention describes novel virus-like particles for use as vaccines, diagnostic tools and R&D tools based on recombinant DNA and cell cultivation techniques for production. The recombinant virus-like particles of the invention are assembled by polypeptide chains that incorporate several, in particular two or more, different epitopes which are selected either (a) from different viral strains of the same virus and/or (b) from different serotypes of the same virus and/or (c) from different viral strains specific for different hosts. These epitopes are then displayed on the particle surface.
Claims
exact text as granted — not AI-modified1 - 16 . (canceled)
17 . A single baculoviral vector encoding a recombinant virus-like particle comprising
(i) two or more polynucleotides coding for different epitopes or different proteins comprising epitopes which are selected either (a) from different viral strains of the same virus and/or (b) from different serotypes of the same virus and/or (c) from different viral strains specific for different hosts; (ii) polynucleotides coding for proteins forming a complete virus-like surface; and (iii) polynucleotides coding for capsid and/or nucleopore proteins.
18 . The baculoviral vector according to claim 17 comprising three or more different epitopes or different proteins comprising epitopes.
19 . The baculoviral vector according to claim 17 comprising four or more different epitopes or different proteins comprising epitopes.
20 . The baculoviral vector according to claim 17 comprising six, nine or twelve epitopes or different proteins comprising epitopes.
21 . The baculoviral vector according to claim 17 wherein the epitopes are from three or more different virus strains or serotypes.
22 . The baculoviral vector according to claim 17 further comprising B- and/or T-cell epitopes.
23 . The baculoviral vector according to claim 17 further comprising fluorescent proteins, proteins useful for purification purposes of the particles or for attaching a label, and/or proteinaceous structures required for transport processes.
24 . The baculoviral vector according to claim 17 wherein the virus is influenza virus.
25 . The baculoviral vector according to claim 17 wherein the virus is human papilloma virus.
26 . A single baculoviral vector comprising a polynucleotide selected from SEQ ID NO:1-5.
27 . A host cell comprising a vector according to claim 17 .
28 . A host cell comprising a vector according to claim 18 .
29 . A host cell comprising a vector according to claim 19 .
30 . A host cell comprising a vector according to claim 20 .
31 . A host cell comprising a vector according to claim 21 .
32 . A host cell comprising a vector according to claim 22 .
33 . A host cell comprising a vector according to claim 23 .
34 . A host cell comprising a vector according to claim 24 .
35 . A host cell comprising a vector according to claim 25 .
36 . A host cell comprising a vector according to claim 26 .Join the waitlist — get patent alerts
Track US2016194662A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.